DrugPatentWatch Database Preview
Cadila Company Profile
What is the competitive landscape for CADILA, and what generic and branded alternatives to CADILA drugs are available?
CADILA has forty-three approved drugs.
There is one tentative approval on CADILA drugs.
Summary for Cadila
| US Patents: | 0 |
| Tradenames: | 36 |
| Ingredients: | 36 |
| NDAs: | 43 |
| Patent Litigation for Cadila: | See patent lawsuits for Cadila |
Drugs and US Patents for Cadila
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cadila | CLOPIDOGREL BISULFATE | clopidogrel bisulfate | TABLET;ORAL | 201686-001 | Oct 10, 2012 | DISCN | No | No | Start Trial | Start Trial | |||||
| Cadila Pharms Ltd | HYDRALAZINE HYDROCHLORIDE | hydralazine hydrochloride | TABLET;ORAL | 203845-003 | Sep 18, 2014 | AA | RX | No | No | Start Trial | Start Trial | ||||
| Cadila Pharms Ltd | GLYBURIDE | glyburide | TABLET;ORAL | 203379-003 | Jan 4, 2019 | AB1 | RX | No | No | Start Trial | Start Trial | ||||
| Cadila | INDOMETHACIN | indomethacin | CAPSULE;ORAL | 090403-002 | Nov 15, 2010 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Cadila Pharms Ltd | CELECOXIB | celecoxib | CAPSULE;ORAL | 208701-002 | Nov 14, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Cadila Pharms Ltd | OFLOXACIN | ofloxacin | TABLET;ORAL | 091656-003 | Sep 18, 2014 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
